STERIS plc
STE · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 4.08 | 1.54 | -2.40 | 1.85 |
| FCF Yield | 0.83% | 1.38% | 0.85% | 1.20% |
| EV / EBITDA | 66.94 | 69.25 | 72.17 | 59.96 |
| Quality | ||||
| ROIC | 2.13% | 1.98% | 1.73% | 2.00% |
| Gross Margin | 44.23% | 45.14% | 43.31% | 44.53% |
| Cash Conversion Ratio | 1.50 | 2.36 | 1.79 | 1.92 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.32% | 3.78% | 3.27% | 2.12% |
| Free Cash Flow Growth | -38.33% | 71.88% | -22.05% | 63.61% |
| Safety | ||||
| Net Debt / EBITDA | 4.46 | 4.87 | 6.03 | 5.79 |
| Interest Coverage | 17.99 | 15.47 | 12.63 | 12.85 |
| Efficiency | ||||
| Inventory Turnover | 1.24 | 1.19 | 1.44 | 1.17 |
| Cash Conversion Cycle | 97.02 | 101.41 | 95.69 | 108.78 |